(A) Transcriptional start site (TSS) usage analysis from FANTOM5 CAGE phase1 and 2 datasets (skeletal muscle is not included) on the last update of Zenbu browser (https://fantom.gsc.riken.jp/zenbu/; …
(A) In situ hybridization (ISH) performed on E13.5 embryonal cryo-sections using digoxigenin-labeled RNA antisense (Charme, left panel) or sense (control, right panel) probes against Charme. T, …
(A) Heatmap visualization from RNA-seq analysis of CharmeWT and CharmeKO neonatal (PN2) hearts. Plot was produced by heatmap3 (Zhao, 2021). Expression values were calculated as FPKM, were log2-transf…
(A) Schematic overview of the workflow to identifying differentially expressed genes (DEGs) from CharmeWT and CharmeKO transcriptomes (left panel). Multidimensional scaling plot of leading fold …
(A) RNA-FISH for pCharme (red) and DAPI staining (blue) in CharmeWT cardiac and spinal cord from E15.5 tissue sections. Whole heart (white dashed lines), spinal cord (yellow dashed line). A, atria; …
(A) Quantification of the subcellular distribution of pCharme and mCharme in cardiac tissues from neonatal mice. Histogram shows the quantification by RT-qPCR of the RNA abundance (%) in cytoplasmic …
(A) Schematic representation of MATR3 CLIP-seq workflow from fetal (E15.5) CharmeWT and CharmeKO hearts. See ‘Materials and methods’ for details. (B) MATR3 CLIP-seq from fetal hearts. Upper panel: a …
(A) Schematic representation of MATR3-CLIP assay as performed from fetal hearts (E15.5) in CharmeWT and CharmeKO conditions. MATR3 Western blot analysis on the retrieved protein fractions is shown. …
(A) Pie charts showing the percentage of MATR3 targets in CharmeKO downregulated, invariant, or upregulated differentially expressed genes (DEGs). Significance of enrichment or depletion was …
(A) Empirical cumulative distribution functions (ECDF) showing the RNA abundance of MATR3 targets in CharmeKO condition compared to the other expressed genes. Significance was determined using a …
At developmental stages (CharmeWT), pCharme is required for the expression of genes involved in cardiomyocyte maturation. This activity is accompanied by the formation of nuclear condensates, …
(A) COTAN heatmap obtained using the whole scRNA-seq dataset showing Charme positive correlation with Tbx5, both expressed in cardiomyocytes, and its negative correlation with Klf2, Pecam1, Sox9 and …
(A) Left panel: RT-qPCR quantification of Hey2 RNA levels in E15. 5 CharmeWT vs CharmeKO cardiac extract. RT-qPCR data were normalized to GAPDH mRNA and represent means ± SEM of WT and KO (n=3) …
Average expression from neonatal (PN) RNA-seq (FPKM) in E15.5 CharmeWT vs CharmeKO cardiac extract of trabeculae marker genes.
RT-qPCR quantification of cell cycle genes mRNA expression in primary cardiac cells treated with si-SCR or si-MATR3. Data were normalized to GAPDH mRNA and represent mean ± SEM of 4 independent …
(A) Contact map depicting Hi-C data of left ventricular mice heart retrived from GEO accession ID GSM2544836. Data related to 1 Mb region around Charme locus were visualized using Juicebox Web App …
Average expression from RNA-seq (FPKM) quantification of Charme neighbouring genes in C2C12 differentiated myotubes treated with Gap-scr vs Gap-Charme. Values for Gap-Charme represent the average …
RT-qPCR quantification Gata4, Nkx2-5 and Tbx5 in CharmeWT and CharmeKO cardiac extract at E12.5, E15.5 and E18.5 days of embryonal development. Data were normalized to GAPDH mRNA and represent means …
Charme Tss usage data collected from Zenbu genome browser.
RNA-seq in CharmeWT and CharmeKO neonatal hearts.
Echocardiography measurement for CharmeWT and CharmeKO animals.
MATR3 CLIP-seq in CharmeWT and CharmeKO fetal hearts.
List and sequences of the oligonucleotides, siRNAs, antibodies, and imaging probes used.